Cited by

• Comparisons of Clinical Features and Outcomes of COVID-19 between Patients with Pediatric Onset Inflammatory Rheumatic Diseases and Healthy Children.

  Haslak F, Varol SE, Gunalp A, Kaynar O, Yildiz M, Adrovic A, Sahin S, Kes G, Ayzit-Kilinc A, Akdeniz B, Onal P, Apaydin G, Aygun D, Arslan H, Kilic-Baskan A, Hepkaya E, Meral O, Barut K, Cokugras HC, Kasapcopur O. Haslak F, et al. J Clin Med. 2022 Apr 9;11(8):2102. doi: 10.3390/jcm11082102. J Clin Med. 2022. PMID: 35456195 Free PMC article.
• Clinical course and seroprevalence of COVID-19 in children with rheumatic diseases-cross-sectional study from a reference centre in Spain.

  Udaondo C, Millán-Longo C, Permuy C, Valladares L, Falces-Romero I, Muñoz-Gómez C, Morales-Higuera M, Alcobendas R, Remesal A, Murias S, Calvo C. Udaondo C, et al. Clin Rheumatol. 2022 Jun;41(6):1779-1784. doi: 10.1007/s10067-022-06186-z. Epub 2022 Apr 30. Clin Rheumatol. 2022. PMID: 35489011 Free PMC article.
• A Big Problem and Debate in COVID-19 Pandemics: Equitable and Effective Access of the COVID-19 Vaccines and Waiver of Intellectual Property.

  Kasapçopur Ö. Kasapçopur Ö. Turk Arch Pediatr. 2021 Jul 1;56(4):283-284. doi: 10.5152/TurkArchPediatr.2021.180621. eCollection 2021 Jul. Turk Arch Pediatr. 2021. PMID: 35005720 Free PMC article. No abstract available.
• Clinical outcomes of tocilizumab therapy in polyarticular and systemic juvenile idiopathic arthritis: a single-center analysis (2018-2022).

  Gazda A, Naishtetik I, Kołodziejczyk B, Rybak K, Mańczak M, Wójtowicz J, Krasowicz-Towalska O, Gietka P. Gazda A, et al. Rheumatol Int. 2024 Dec;44(12):2949-2959. doi: 10.1007/s00296-024-05711-4. Epub 2024 Sep 23. Rheumatol Int. 2024. PMID: 39311914 Free PMC article.
• The impact of the COVID-19 pandemic on the field of pediatric rheumatology.

  Wahezi DM, Peskin M, Tanner T. Wahezi DM, et al. Curr Opin Rheumatol. 2021 Sep 1;33(5):446-452. doi: 10.1097/BOR.0000000000000814. Curr Opin Rheumatol. 2021. PMID: 34175864 Free PMC article. Review.